Richard A. Kahn
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Richard A. Kahn.
The FASEB Journal | 1992
Richard A. Kahn; Channing J. Der; Gary M. Bokoch
therasoncogeneproteinshasbeendescribed(1-4).Thenumberofmembersofthissuperfamily identified hasincreaseddra-matically inrecentyears,andthenumber ofdescriptivetermsornamesusedtodenotetheseproteinshasincreasedalmostasdramatically aswell.During therecentFASEBSummer ResearchConference on“LowMolecular WeightGTPBinding Proteins:’aninformal sessiononnomencla-turewasheldinanefforttoestablishguidelinesforthelitera-tureinthisrapidlyexpanding field,aswellasinthenamingofnewgenesandproteins. Theneedforsuchasessionclearlyresultsfromtheabundance ofsequenceinformationonnewgenesandproteinsandtherelativepaucityofinfor-mationregarding proteinfunction, acommonthemeinthebiological sciencestoday.Thediscussion focusedonthreemainquestions:
FEBS Letters | 1986
Judith Falloon; Harry L. Malech; Graeme Milligan; Cecilia G. Unson; Richard A. Kahn; Paul Goldsmith; Allen M. Spiegel
Antisera raised against the carboxy‐terminal decapeptide (KENLKDCGLF) of transducin‐α detected the 40 kDa, major pertussis toxin substrate of human neutrophils. The antisera also detected this protein in undifferentiated HL‐60 and U937 cells, and revealed an approx. 2‐fold increase in protein/mg membrane protein with differentiation into mature phagocytic cells. The results provide direct immunochemical evidence for the presence of a novel, pertussis toxin‐sensitive guanine nucleotide‐binding protein in human leukocytes.
Protein Expression and Purification | 1992
Barry Burnette; Richard A. Kahn; Constance J. Glover; Ronald L. Felsted
The coding region of the N-terminal 17-kDa portion of HIV-1 Pr55gag (p17gag) was cloned into the pET-3c expression vector and was used to overexpress HIV-1 p17gag in Escherichia coli. Induction of the transformed bacteria caused the accumulation of a 17-kDa polypeptide in the soluble cell fraction which was released by sonication in hypotonic nondetergent buffer. The 17-kDa polypeptide was purified by ammonium sulfate precipitation and successive chromatography on G-75 Sephadex, DEAE-Sephacel, and S-Sephadex. The final product was purified 12-fold with about a 16% recovery from the original soluble cell lysate and was judged to be 97+% pure by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Western blotting with two different antibodies confirmed the identify of the purified 17-kDa polypeptide as authentic p17gag. In the presence of myristoyl-CoA and bovine brain N-myristoyl-transferase, p17gag was quantitatively N-myristoylated in vitro with a pseudo-first-order rate constant of 4.7 +/- 1.0 x 10(-3) min-1, but with only about 3% of the catalytic efficiency of N-myristoylation of a 16-residue peptide homologous to the N-terminus of p17gag. The myristate group in the N-myristoylated p17gag was stable to treatment with detergent and hydroxylamine consistent with a covalent N-acyl-amide linkage. The N-myristoylglycyl linkage was confirmed by partial acid hydrolysis and identification of the p-nitrobenzylazlactone derivative of the resulting N-myristoylglycine by high-performance liquid chromatography.
Journal of Chromatography A | 1991
Martha Knight; Sara Gluch; Kazuyuki Takahashi; Truc T. Dang; Richard A. Kahn
A preparative purification of myristyl-Gly-Asn-Ile-Phe-Ala-Asn-Leu-Phe-Lys-Gly-Leu-Phe-Gly-Lys-Lys-Glu -NH2 was accomplished using the multi-coil counter-current chromatograph. A partition coefficient was determined in the n-butanol-acetic acid-water (4:1:5) system. Chromatographic runs were made in this system and one modified with ethyl acetate. The peptide material showed anomalous elution behavior due to its surfactant properties. It was found that by loading the sample exclusively in the stationary phase, satisfactory retention of the compound occurred. Finally, conditions utilizing the upper phase as the mobile phase successfully separated the impurities.
Journal of Biological Chemistry | 1996
Jon W. Erickson; Chun-jiang Zhang; Richard A. Kahn; Tony Evans; Richard A. Cerione
Journal of Biological Chemistry | 1991
Richard A. Kahn; F G Kern; Jenny Clark; E P Gelmann; C Rulka
Journal of Biological Chemistry | 1995
Paul A. Randazzo; Takeshi Terui; Stacey Sturch; Henry M. Fales; Anthony G. Ferrige; Richard A. Kahn
Journal of Biological Chemistry | 1995
Richard A. Kahn; Jenny Clark; Cherrie Rulka; Tim Stearns; Chun-jiang Zhang; Paul A. Randazzo; Takeshi Terui; Margaret M. Cavenagh
The cancer journal from Scientific American | 1996
Edward A. Sausville; Kimberly L K Duncan; Adrian M. Senderowicz; Jacqueline Plowman; Paul A. Randazzo; Richard A. Kahn; Louis Malspeis; Michael R. Grever
Archive | 1994
Takeshi Terui; Richard A. Kahn; Paul A. Randazzo
Collaboration
Dive into the Richard A. Kahn's collaboration.
University of Texas Health Science Center at San Antonio
View shared research outputsUniversity of Texas Health Science Center at San Antonio
View shared research outputs